Papillary Renal Cell Carcinoma: Demographics, Survival Analysis, Racial Disparities, and Genomic Landscape [0.03%]
乳头状肾细胞癌：人口统计学、生存分析、种族差异和基因组特征
Asad Ullah,Abdul Qahar Khan Yasinzai,Naema Daino et al.
Asad Ullah et al.
Papillary renal cell carcinoma (PRCC) is the second most common histological subtype of renal cell cancer. This research aims to present a large database study highlighting the demographic, clinical, and pathological factors, racial dispari...
Exploring Renal Malignancies in Saudi Arabia: Insights from a Tertiary Care Center Study [0.03%]
沙特阿拉伯肾恶性肿瘤的探索：三级护理中心研究的见解
Ahmed Alasker,Turki Rashed Alnafisah,Mohammad Alghafees et al.
Ahmed Alasker et al.
This retrospective study aims to describe the characteristics of renal cell carcinoma (RCC) in Saudi Arabia, in terms of epidemiology, clinical presentation, tumor subtype, Fuhrman grade, tumor size and stage, and overall survival. A total ...
Characteristics of the Patients Aged Less than 40 Years Operated for a Renal Mass [0.03%]
肾肿块手术患者中40岁以下患者的临床特点
Abdullah Ilktac,Bayram Dogan,Cevper Ersoz et al.
Abdullah Ilktac et al.
The incidence of renal cell cancer (RCC) is low in individuals aged less than 40 years; however several studies have shown this increasing trend over the years. Hereditary syndromes are associated with RCC and are more frequently observed i...
Sarcomatoid Carcinoma Metastasis to the Colon from a Small Renal Mass: Case Report with Review of Literature [0.03%]
小肾占位继发大肠肉瘤样癌转移：1例报告及文献复习
Shailesh Patidar,Arun Ramdas Menon,Shirley Sundersingh et al.
Shailesh Patidar et al.
A third of patients with renal cell carcinoma (RCC) present with metastatic disease. Metastasis in RCC from small renal mass (SRM) (≤4 cm) is rare. We report a case of stage cT1a clear-cell RCC with low-risk features on pathology presentin...
Advancing Treatment Frontiers: Radiofrequency Ablation for Small Renal Mass-Intermediate-Term Results [0.03%]
治疗的前沿进展：小肾脏肿瘤射频消融的中期结果分析
Rohit Kumar Singh,Manav Gideon,Rohan Rajendran et al.
Rohit Kumar Singh et al.
Our study aims to discern the immediate and intermediate-term oncological outcomes of the patients with small renal mass and who were surgically unfit or were having a bilateral tumor and underwent radiofrequency ablation (RFA) of the mass....
Case Reports of TFE3-Rearranged Renal Cell Carcinoma: FDG-PET Uptake Might Help Diagnosis [0.03%]
TFE3重排肾细胞癌病例报告--FDG-PET摄取有助于诊断
Sho Murakami,Keita Nagawa,Takanori Inui et al.
Sho Murakami et al.
Translocation and transcription factor E3 (TFE3)-rearranged renal cell carcinoma (RCC) is a rare subtype of RCCs characterised by the fusion of the TFE3 transcription factor genes on chromosome Xp11.2 with one of the multiple genes. TFE3-re...
Systemic Treatment for Advanced and Metastatic Non-Clear Cell Renal Cell Carcinoma: Examining Modern Therapeutic Strategies for a Notoriously Challenging Malignancy [0.03%]
晚期和转移性非透明细胞肾细胞癌的系统治疗：评估针对这一棘手恶性肿瘤的现代治疗方法
Jake Drobner,Daniella Portal,Karie Runcie et al.
Jake Drobner et al.
Non-clear cell renal cell carcinoma (nccRCC) is a heterogeneous group of malignancies that represents 25% of renal cell carcinoma (RCC) cases. Treatment for non-clear cell histologies is mostly based on evidence from small phase II clinical...
Recent Improvements in Adult Wilms Tumor Diagnosis and Management: Review of Literature [0.03%]
近年肾母细胞瘤诊疗近况回顾
Vishnupriya Sakthivel,Ismail Z Adeeb,Devashree Vijayabalan
Vishnupriya Sakthivel
Wilms tumor, also denoted as nephroblastoma, an embryonal type of renal cancer, is the most common cancer that affects children in the first 5 years of life. Wilms tumor is very rarely seen in adults. Both adults and children showcase varie...
Von Hippel-Lindau Disease (VHL): Characteristic Lesions with Classic Imaging Findings [0.03%]
von Hippel-Lindau病（VHL）：具有经典影像学表现的特征性病变
Suryansh Bajaj,Darshan Gandhi,Divya Nayar et al.
Suryansh Bajaj et al.
Von Hippel-Lindau disease (VHL) is a multisystem cancer syndrome caused by the inactivation of the VHL tumor suppressor gene and involves various organ systems including the central nervous system (CNS), endocrine system, and the kidneys. T...
Hereditary Renal Cell Carcinoma: Is Age an Independent Criterion for Genetic Testing? A Large Cohort from a Latin America Referral Center [0.03%]
遗传性肾细胞癌：年龄是拉丁美洲转诊中心一大型群体中进行基因检测的独立指标吗？
Tomás Carminatti,Patricio Aitor García Marchiñena,Ignacio Pablo Tobia González et al.
Tomás Carminatti et al.
Although age younger than 46 years has been an independent criterion for genetic testing in hereditary renal cell carcinoma (hRCC), there is a lack of evidence in the literature. This study aims to analyze whether a 46-year-old cut-off shou...